Clinical trial
Prognostic Markers of Patients With ST-segment Elevation Myocardial Infarction
NCT03527940 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Markers of Patients With ST-segment Elevation Myocardial Infarction
- Lead sponsor
- Chongqing Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 17, 2015
- Completion date
- January 1, 2020
- Enrollment
- 932 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stemi - st elevation myocardial infarction